Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-3 of 3
Keywords: Escitalopram
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
Available to PurchaseSubject Area:
Psychiatry and Psychology
Sahar Mohamed El-Haggar, Mai AbdelRaouf Eissa, Tarek Mohammed Mostafa, Khaled Sabry El-Attar, Mahmoud Samy Abdallah
Journal:
Psychotherapy and Psychosomatics
Psychother Psychosom (2018) 87 (6): 331–339.
Published Online: 11 September 2018
... in the trial. Patients were required to have a baseline Hamilton Rating Scale for Depression (HAM-D) score of at least 18. Patients were allocated randomly: 40 received escitalopram 20 mg/day plus placebo while the other 40 received escitalopram 20 mg/day plus PTX (400 mg b.i.d.). Patients were assessed...
Journal Articles
Cognitive Behavioral Analysis System of Psychotherapy versus Escitalopram in Chronic Major Depression
Available to PurchaseSubject Area:
Psychiatry and Psychology
Elisabeth Schramm, Ingo Zobel, Dieter Schoepf, Thomas Fangmeier, Knut Schnell, Henrik Walter, Sarah Drost, Paul Schmidt, Eva-Lotta Brakemeier, Mathias Berger, Claus Normann
Journal:
Psychotherapy and Psychosomatics
Psychother Psychosom (2015) 84 (4): 227–240.
Published Online: 23 May 2015
...), was compared to escitalopram (ESC). Methods: Sixty patients with chronic major depression were randomized to ‘CBASP' (22 sessions) or ‘ESC plus clinical management' (ESC/CM) at two treatment sites. The primary outcome measure was the score on the Montgomery-Asberg Depression Rating Scale (MADRS) after 8 weeks...
Journal Articles
Escitalopram: Superior to Citalopram or a Chiral Chimera?
Available to PurchaseSubject Area:
Psychiatry and Psychology
Journal:
Psychotherapy and Psychosomatics
Psychother Psychosom (2004) 73 (1): 10–16.
Published Online: 12 December 2003
...Staffan Svensson; Peter R. Mansfield Background: Escitalopram is the active isomer of the antidepressant citalopram. In theory single-isomer drugs may be superior but few have been found to have clinically significant advantages. The manufacturer claims that escitalopram has more efficacy...